Zobrazeno 1 - 10
of 675
pro vyhledávání: '"Herbert L DuPont"'
Autor:
Heather T Essigmann, Kristi L Hoffman, Joseph F Petrosino, Goo Jun, David Aguilar, Craig L Hanis, Herbert L DuPont, Eric L Brown
Publikováno v:
PLoS ONE, Vol 16, Iss 10, p e0258812 (2021)
Secretory IgA (SIgA) is released into mucosal surfaces where its function extends beyond that of host defense to include the shaping of resident microbial communities by mediating exclusion/inclusion of respective microbes and regulating bacterial ge
Externí odkaz:
https://doaj.org/article/0324ed888d4c44ccb83aef011272f046
Autor:
Zhi-Dong Jiang, Robert R Jenq, Nadim J Ajami, Joseph F Petrosino, Ashley A Alexander, Shi Ke, Tehseen Iqbal, Andrew W DuPont, Kenneth Muldrew, Yushu Shi, Christine Peterson, Kim-Anh Do, Herbert L DuPont
Publikováno v:
PLoS ONE, Vol 13, Iss 11, p e0205064 (2018)
BACKGROUND:Fecal microbiota transplantation (FMT) via colonoscopy or enema has become a commonly used treatment of recurrent C. difficile infection (CDI). AIMS:To compare the safety and preliminary efficacy of orally administered lyophilized microbio
Externí odkaz:
https://doaj.org/article/a19461a15e4d4f5685a929aa6697520a
Publikováno v:
Therapeutics and Clinical Risk Management, Vol 2009, Iss default, Pp 841-848 (2009)
Hoonmo L Koo1,2, Herbert L DuPont1,2, David B Huang31Baylor College of Medicine, Houston, TX, USA; 2University of Texas at Houston School of Public Health, Houston, TX, USA; 3Veterans Affairs Medical Center, East Orange, NJ, USAAbstract: Travelers’
Externí odkaz:
https://doaj.org/article/fdf920436ba9484d81524316477a2b2e
Autor:
Samuel L Aitken, Tiby B Joseph, Dhara N Shah, Todd M Lasco, Hannah R Palmer, Herbert L DuPont, Yang Xie, Kevin W Garey
Publikováno v:
PLoS ONE, Vol 9, Iss 7, p e102848 (2014)
BackgroundThere are limited data examining healthcare resource utilization in patients with recurrent Clostridium difficile infection (CDI).MethodsPatients with CDI at a tertiary-care hospital in Houston, TX, were prospectively enrolled into an obser
Externí odkaz:
https://doaj.org/article/59e6bad0f6d745e8a322d6e9332c320f
Publikováno v:
PLoS ONE, Vol 9, Iss 3, p e93144 (2014)
Irritable bowel syndrome (IBS) is one of the most frequently diagnosed disorders, affecting about 20% of the general population in Western countries. This syndrome poses an enormous socio-economic burden, impairs the quality of life substantially, an
Externí odkaz:
https://doaj.org/article/eba087c6b03549b1b918196cbd52dc2a
Publikováno v:
PLoS ONE, Vol 8, Iss 11, p e79631 (2013)
Virulent Clostridium difficile strains produce toxin A and/or toxin B that are the etiological agents of diarrhea and pseudomembranous colitis. Treatment of C. difficile infections (CDI) has been hampered by resistance to multiple antibiotics, sporul
Externí odkaz:
https://doaj.org/article/3a3eadf09c7b4c058dccb550bea934f6
Publikováno v:
PLoS ONE, Vol 8, Iss 7, p e68550 (2013)
Rifaximin is a semi-synthetic rifamycin derivative that is used to treat different conditions including bacterial diarrhea and hepatic encephalopathy. Rifaximin is of particular interest because it is poorly adsorbed in the intestines and has minimal
Externí odkaz:
https://doaj.org/article/deaaf666e1e64556bbd4a368db8c0728
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 17 (2024)
Microbiota restoration therapy has become a standard treatment for recurrent Clostridioides difficile infection (rCDI). In this article, we review the studies supporting the licensure of two live biotherapeutic products (LBPs) designed to prevent rCD
Externí odkaz:
https://doaj.org/article/509f63eadffd4d5d8e178107c1b0c53c
Autor:
Herbert L. DuPont, Jessika Suescun, Zhi-Dong Jiang, Eric L. Brown, Heather T. Essigmann, Ashley S. Alexander, Andrew W. DuPont, Tehseen Iqbal, Netanya S. Utay, Michael Newmark, Mya C. Schiess
Publikováno v:
Frontiers in Neurology, Vol 14 (2023)
Background and purposeThe intestinal microbiome plays a primary role in the pathogenesis of neurodegenerative disorders and may provide an opportunity for disease modification. We performed a pilot clinical study looking at the safety of fecal microb
Externí odkaz:
https://doaj.org/article/88b4025447874d668ccffb35a579c6ce
Publikováno v:
Antibiotics, Vol 12, Iss 11, p 1617 (2023)
Background: The microbiome of newborn infants during the first 1000 days, influenced early on by their mothers’ microbiome health, mode of delivery and breast feeding, orchestrates the education and programming of the infant’s immune system and d
Externí odkaz:
https://doaj.org/article/db47054e43f64d29b07928bc6725bf0e